Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers
@article{CCO103542, author = {Axel Grothey}, title = {Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers}, journal = {Chinese Clinical Oncology}, volume = {11}, number = {5}, year = {2022}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/103542} }